Výsledky vyhledávání

Advantages and Disadvantages of Different Implementation Strategies of Non-Invasive Prenatal Testing in Down Syndrome Screening Programmes

Autor: A. Coumans, Suzanna G.M. Frints, C.E.M. de Die-Smulders, Luc J.M. Smits, Joris A. Veltman, Elke Mersy, G. de Wert

Publikováno v: Public Health Genomics, 18, 260-71
Public Health Genomics, 18, 5, pp. 260-71
Public Health Genomics, 18(5), 260-271. Karger

Background: Implementation of non-invasive prenatal testing (NIPT) in Down syndrome screening programmes requires health policy decisions about its combination with other tests and its timing in pregnancy. Aim: Our aim was to aid health policy decisi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b18ab263cf8b2d49c89a478ad2221023
https://doi.org/10.1159/000435780

Zobrazit plný text záznamu

Noninvasive detection of fetal trisomy 21: systematic review and report of quality and outcomes of diagnostic accuracy studies performed between 1997 and 2012

Autor: A. Coumans, Luc J.M. Smits, C. E. M. De Die-Smulders, Aimee D C Paulussen, Merryn V. E. Macville, L.A.A.P. van Winden, Suzanna G.M. Frints, Elke Mersy

Publikováno v: Human Reproduction Update, 19(4), 318-329. Oxford University Press

BACKGROUND Research on noninvasive prenatal testing (NIPT) of fetal trisomy 21 is developing fast. Commercial tests have become available. To provide an up-to-date overview of NIPT of trisomy 21, an evaluation of the methodological quality and outcom

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8fc75a3b93f89be02465af984e2c47a
https://doi.org/10.1093/humupd/dmt001

Zobrazit plný text záznamu

Noninvasive prenatal screening and diagnosis

Autor: Elke Mersy

The blood of a pregnant woman contains DNA from her unborn child. This DNA can be tested by taking a blood sample from the mother-to-be. In this dissertation, a blood sample was used to determine the sex of the baby and to test for the inheritance of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e19a7a14df668efacfa35d58c511938
https://doi.org/10.26481/dis.20161207em

Zobrazit plný text záznamu

Cell-Free RNA Is a Reliable Fetoplacental Marker in Noninvasive Fetal Sex Determination

Autor: Suzanna G.M. Frints, Joris A. Veltman, Merryn V. E. Macville, Brigitte H. W. Faas, Aimee D C Paulussen, Sabine Spierts, Elke Mersy, Leonie M.H. Houben

Publikováno v: Clinical Chemistry, 61(12), 1515-1523. American Association for Clinical Chemistry
Clinical Chemistry, 61, 1515-23
Clinical Chemistry, 61, 12, pp. 1515-23

BACKGROUNDNoninvasive genetic tests that use cell-free fetal DNA (cffDNA) are used increasingly in prenatal care. A low amount of cffDNA can have detrimental effects on the reliability of these tests. A marker to confirm the presence of fetal nucleic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0c3a9f8b7379986b22e742071522148
https://pubmed.ncbi.nlm.nih.gov/26467504

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání